Detailed price information for Kiora Pharmaceuticals Inc. (KPRX-Q) from The Globe and Mail including charting and trades.

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

India gains ground in excipients globally as manufacturers add capacity, improve compliance: Amit Raj Sinha: Shardul Nautiyal, Mumbai Wednesday, December 24, 2025, 08:00 Hrs [IST] ...

Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.

With several sites activated and recruitment ongoing, the Phase IIb trial is projected to deliver top-line outcomes next year ...

APIs are a critical component in pharma manufacturing and nearly 65-70% of supplies in India come from China. The government ...

The global generic pharmaceuticals contract manufacturing market size is valued at USD 81.24 billion in 2025 and is predicted to hit around USD 143.22 billion by 2035, rising at a 5.85% CAGR, a study ...

The Phase IIb study will enroll approximately 87 participants and evaluate two therapeutic doses of psilocybin against a low-dose comparator, combined with structured psychotherapy. With multiple ...

The White House Fact Sheet recognizes that marijuana has a "currently accepted medical use" and notes that the lack of FDA approval leaves six million registered patients and 30,000 practitioners ...

Sudarshan Pharma Industries Limited has incorporated a wholly owned subsidiary in Poland, Sudarshan Pharma Poland Limited ...

The global Temperature Controlled Package for Pharmaceutical market revenue was USD 4215 Million in 2022 and is forecast to a readjusted size of USD 9343.6 Million by 2029 with a CAGR of 11.9% during ...

Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...